| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antioxidant treatment of tardive dyskinesia
|
Rotrosen, John
|
|
1996
|
55 |
1-2 |
p. 77-81
5 p.
|
article
|
| 2 |
Decreased tyrosine transport in fibroblasts from schizophrenics: Implications for membrane pathology
|
Ramchand, C.N.
|
|
1996
|
55 |
1-2 |
p. 59-64
6 p.
|
article
|
| 3 |
Dyskinesias and their treatment with essential fatty acids: a review
|
Vaddadi, Krishna
|
|
1996
|
55 |
1-2 |
p. 89-94
6 p.
|
article
|
| 4 |
Editorial Board
|
|
|
1996
|
55 |
1-2 |
p. i-
1 p.
|
article
|
| 5 |
Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation
|
Peet, M.
|
|
1996
|
55 |
1-2 |
p. 71-75
5 p.
|
article
|
| 6 |
Essential fatty acids and abnormal involuntary movements in the general male population: a study of men born in 1933
|
Nilsson, Agneta
|
|
1996
|
55 |
1-2 |
p. 83-87
5 p.
|
article
|
| 7 |
Free radical pathology in schizophrenia: a review
|
Reddy, Ravinder D.
|
|
1996
|
55 |
1-2 |
p. 33-43
11 p.
|
article
|
| 8 |
Heat stress lipids and schizophrenia
|
Bates, P.R.
|
|
1996
|
55 |
1-2 |
p. 101-107
7 p.
|
article
|
| 9 |
Incorporation of 3H-arachidonic acid into platelet phospholipids of patients with schizophrenia
|
Yao, J.K.
|
|
1996
|
55 |
1-2 |
p. 21-26
6 p.
|
article
|
| 10 |
In memoriam: Sukdeb Mukherjee MD, 1946–1995
|
Horrobin, David
|
|
1996
|
55 |
1-2 |
p. 1-
1 p.
|
article
|
| 11 |
Membrane fatty acids, niacin flushing and clinical parameters
|
Glen, A.I.M.
|
|
1996
|
55 |
1-2 |
p. 9-15
7 p.
|
article
|
| 12 |
Oxidative injury and potential use of antioxidants in schizophrenia
|
Mahadik, S.P.
|
|
1996
|
55 |
1-2 |
p. 45-54
10 p.
|
article
|
| 13 |
Phospholipase A2 and the hypofrontality hypothesis of schizophrenia
|
Gattaz, Wagner F.
|
|
1996
|
55 |
1-2 |
p. 109-113
5 p.
|
article
|
| 14 |
Phospholipases: in search of a genetic base of schizophrenia
|
Hudson, Craig J.
|
|
1996
|
55 |
1-2 |
p. 119-122
4 p.
|
article
|
| 15 |
31P magnetic responance spectroscopy studies in schizophrenia
|
Williamson, P.C.
|
|
1996
|
55 |
1-2 |
p. 115-118
4 p.
|
article
|
| 16 |
Reduced susceptibility to oxidative damage of erythrocyte membranes from medicated schizophrenic patients
|
Ramchand, C.N.
|
|
1996
|
55 |
1-2 |
p. 27-31
5 p.
|
article
|
| 17 |
Schizophrenia as a membrane lipid disorder which is expressed throughout the body
|
Horrobin, David F.
|
|
1996
|
55 |
1-2 |
p. 3-7
5 p.
|
article
|
| 18 |
The lipid membrane hypothesis of schizophrenia: implications for possible clinical breath tests
|
Dodd, G.H.
|
|
1996
|
55 |
1-2 |
p. 95-99
5 p.
|
article
|
| 19 |
The niacin challenge test in schizophrenia: past, present and future
|
Lin, A.
|
|
1996
|
55 |
1-2 |
p. 17-19
3 p.
|
article
|
| 20 |
Tyrosine transport as an indicator of cell membrane dysfunction in schizophrenia
|
Wiesel, F.-A.
|
|
1996
|
55 |
1-2 |
p. 55-58
4 p.
|
article
|
| 21 |
Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls
|
Mahadik, S.P.
|
|
1996
|
55 |
1-2 |
p. 65-70
6 p.
|
article
|
Journal description